Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America.
about
Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Inactivated polio vaccines fro ...... rolled trial in Latin America.
@ast
Inactivated polio vaccines fro ...... rolled trial in Latin America.
@en
type
label
Inactivated polio vaccines fro ...... rolled trial in Latin America.
@ast
Inactivated polio vaccines fro ...... rolled trial in Latin America.
@en
prefLabel
Inactivated polio vaccines fro ...... rolled trial in Latin America.
@ast
Inactivated polio vaccines fro ...... rolled trial in Latin America.
@en
P2093
P2860
P1433
P1476
Inactivated polio vaccines fro ...... rolled trial in Latin America.
@en
P2093
Ananda S Bandyopadhyay
Bhavesh R Borate
Eduardo Lopez-Medina
Edwin J Asturias
James T Gaensbauer
Mario Melgar
Ralf Clemens
Ricardo Rüttimann
P2860
P304
P356
10.1016/J.VACCINE.2017.04.041
P407
P577
2017-04-25T00:00:00Z